Eating disorders: predictors of development in disorders of carbohydrate metabolism
https://doi.org/10.52485/19986173_2023_1_137
Abstract
Currently, there is more and more information about the influence of eating disorders on the formation of socially significant chronic non-infectious diseases and metabolic disorders, including obesity, impaired carbohydrate tolerance, and type 2 diabetes mellitus.
The purpose of this literature review was to summarize information about the mechanisms of regulation of eating behavior and to characterize their features in patients with carbohydrate disorders.
Аccording to the results of the search, the factors that increase the risk of developing eating disorders, in addition to hereditary predisposition, include the female gender, younger age, high BMI, and concomitant mental illness. Eating disorders are quite common among patients suffering from both early disorders of carbohydrate metabolism and diabetes mellitus. Disturbed eating patterns may act as additional contributing factors to the development of type 2 diabetes, while type 1 diabetes is a predictor of the development of eating disorders. Eating disorders in persons with metabolic disorders contribute to the deterioration of glycemic control, the development of dyslipidemia, and generally worsen the control of the disease.
Supporting agencies: The authors state that there was no sponsorship during the study
About the Authors
D. N. Isakova
Tyumen State Medical University
Russian Federation
Russian Federation
625023; 54 Odesskaya str.; Tyumen
I. M. Petrov
Tyumen State Medical University
Russian Federation
Russian Federation
625023; 54 Odesskaya str.; Tyumen
E. A. Evgenyeva
Tyumen State Medical University
Russian Federation
Russian Federation
625023; 54 Odesskaya str.; Tyumen
A. A. Kurmangulov
Tyumen State Medical University
Russian Federation
Russian Federation
625023; 54 Odesskaya str.; Tyumen
I. A. Troshina
Tyumen State Medical University
Russian Federation
Russian Federation
625023; 54 Odesskaya str.; Tyumen
T. N. Vasilkova
Tyumen State Medical University
Russian Federation
Russian Federation
625023; 54 Odesskaya str.; Tyumen
References
1. Bolotova N.V., Kurdiyan M.S., Filina N.Yu. Neuroendocrine mechanisms of regulation of eating behavior (review). Saratovskij nauchno-medicinskij zhurnal 2020. 16 (3). 707-713. in Russian.
2. Skugarevskij O.A. Eating disorders : monograph. Minsk. BGMU. 2007. 340. in Russian.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing. 2013. 87-122.
4. Vlasova S.A., Azisova E`.M., Isakova DN., Kurmangulov A.A. Difficulties in Diagnosing Carbohydrate Metabolism Disorders in Primary Health Care. Medicinskaya nauka i obrazovanie Urala. 2020. 2 (102). 87-90. doi: 10.36361/1814-8999-2020-21-2-87-90. in Russian.
5. Kibitov A.O., Mazo G.E`. Genetic studies of eating disorders: way out of the vicious circle of nosological systematics. 2016. 26 (4). 63-70. in Russian.
6. Pursey K.M., Hay P., Bussey K., Trompeter N., Lonergan A., Pike K.M., Mitchison D. Diabetes and disordered eating behaviours in a community-based sample of Australian adolescents. Journal of Eating Disorders. 2020. 8(1). doi: 10.1186/s40337-020-0282-y.
7. Baldini G., Phelan K.D. The melanocortin pathway and control of appetite-progress and therapeutic implications. J Endocrinol. 2019. 241 (1). 1-33.
8. Duan D.M., Jhang J.Y., Wu S., et al. Modification effect of sex and obesity on the correlation of LEP polymorphisms with leptin levels in Taiwanese obese women. Mol Genet Genomic Med. doi: 10.1002/mgg3.1113
9. Tikhonenko E.V., Czoj U.A., Vasil`eva E.Yu., Babenko A.Yu. Eating characteristics and appetite-regulating hormone levels in patients with type 2 diabetes mellitus and a body mass index greater than 35 kg/m<sup>2</sup>. Ozhirenie i metabolizm. 2018. 15(1). 30-38. doi: 10.14341/OMET2018130-38. in Russian.
10. Londraville R.L., Prokop J.W., Duff R.J., et al. On the molecular evolution of leptin, leptin receptor, and endospanin. Front Endocrinol (Lausanne). 2017. 8-58. doi: 10.3389/fendo.2017.00058.
11. Al Qarni A.A., Joatar F.E., Das N., et al. Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects. Endocrinol Metab (Seoul). 2017. 32 (2). 230-240. doi: 10.3803/EnM.2017.32.2.230.
12. Ali T.M., Mehanna O.M., El Askary A. The association between ghrelin levels and markers of arterial stiffness and inflammatory markers in Saudi subjects with metabolic syndrome. Diabetes Metab Syndr. 2017. 11 (2). 721-725. doi: 10.1016/j.dsx.2017.05.005.
13. Klimontov V.V., Bulumbaeva D.M., Fazullina O.N. et al. Ghrelin deficiency in patients with type 2 diabetes mellitus: relationship with obesity, adipose tissue dysfunction and glycemic variability. Terapevticheskij arhiv. 2019. 91(10). 28-33. DOI: 10.26442/00403660.2019.10.000150. in Russian.
14. Xing Y.X., Yang L., Kuang H.Y., Gao X.Y., Liu H.L. Function of obestatin in the digestive system. Nutrition. 2017. 34. 21-28.
15. Achari A.E., Jain S.K. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci. 2017. 18 (6). 1321.
16. Parfenova N.S., Tanyansky D.A. Adiponectin: effects on metabolic and cardiovascular disorders. Arterial Hypertension. 2013. 19 (1). 84-96.
17. Gupta P., Bala M., Gupta S., et al. Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action. Pharmacol Res. 2016. 113. 636-74.
18. Engel J.A., Jerlhag E. Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy. CNS Drugs. 2014. 28(10). 875-886. doi: 10.1007/s40263-014-0178-y.
19. Helder S.G., Collier D.A. The genetics of eating disorders. Curr. Top. Behav. Neurosci. 2011. 6. 157-175. doi: 10.1007/7854_2010_79
20. Rozenblat V., Ong D., Fuller-Tyszkiewicz M., Akkermann K., Collier D., Engels R. C.M.E., Krug I. A systematic review and secondary data analysis of the interactions between the serotonin transporter 5-HTTLPR polymorphism and environmental and psychological factors in eating disorders. Journal of Psychiatric Research. 2017. 84. 62-72. doi: 10.1016/j.jpsychires.2016.09.023
21. Mikolajczyk E., Grzywacz A., Samochowiec J. The association of catechol-O-methyltransferase genotype with the phenotype of women with eating disorders. Brain Res. 2010. 1307. 142-148.
22. Ishiguro H., Onaivi E.S., Horiuchi Y., Imai K., Komaki G., et al. Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. Synapse. 2011. 65. 103-108.
23. Miyasaka K., Hosoya H., Sekime A., Ohta M., Amono H., et al. Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population. J. Neural Transm. 2006. 113. 1279-1285.
24. Monteleone P., Tortorella A., Castaldo E., Maj M. Association of a functional serotonin transporter gene polymorphism with binge eating disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006. 141. 7-9.
25. Genzer Y. et al. Effect of dietary fat and the circadian clock on the expression of brain- derived neurotrophic factor (BDNF). Molecular and cellular endocrinology. 2016. 430. 49-55. doi: 10.1016/j.mce.2016.04.015.
26. Castellini G., Franzago M., Bagnoli S., et al. Fat mass and obesity-associated gene (FTO) is associated to eating disorders susceptibility and moderates the expression of psychopathological traits. 2017. 12 (3). doi: 10.1371/journal.pone.0173560.
27. Nagata J. M., Garber A. K., Tabler J. L., Murray S. B., Bibbins-Domingo K. Prevalence and Correlates of Disordered Eating Behaviors Among Young Adults with Overweight or Obesity. Journal of General Internal Medicine. 2018. 33 (8). 1337-1343. doi: 10.1007/s11606-018-4465-z.
28. Petroni M.L., Barbanti F.A., Bonadonna R., Bruno G., Caletti M.T., Croci M., Marchesini G. Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations. Nutrition, Metabolism and Cardiovascular Diseases. 2019. doi: 10.1016/j.numecd.2019.06.006.
29. Nip A.S.Y., Reboussin B.A., Dabelea D., et al. Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2019. doi: 10.2337/dc18-2420.
30. Yang F., Liu A., Li Y., Lai Y., Wang G., Sun C., Teng W. Food Addiction in Patients with Newly Diagnosed Type 2 Diabetes in Northeast China. Frontiers in Endocrinology. 2017. 8. doi: 10.3389/fendo.2017.00218.
31. García-Mayor R., García-Soidán F., Salgado Barreira A. Prevalence of Eating Disorders in Individuals with Type 2 Diabetes: A Cohort Comparison of Patients and Controls. Experimental and Clinical Endocrinology & Diabetes Reports. 2017. 04 (01). 7-9. doi: 10.1055/s-0043-103347.
32. Parry S., Woods R., Hodson L., Hulston C. A Single Day of Excessive Dietary Fat Intake Reduces Whole-Body Insulin Sensitivity: The Metabolic Consequence of Binge Eating. Nutrients. 2017. 9 (8). 818. doi: 10.3390/nu9080818.
33. Nieto-Martínez R., González-Rivas J.P., Medina-Inojosa J.R., Florez H. Are Eating Disorders Risk Factors for Type 2 Diabetes? A Systematic Review and Meta-analysis. Current Diabetes Reports. 2017. 17 (12). doi: 10.1007/s11892-017-0949-1.
34. Isakova D.N., Dorodneva E.F., Belokry`lova L.V., Kurmangulov A.A., Petrov I.M. The role of nutritional factors in the formation of cardiovascular risk in patients with type 2 diabetes mellitus. Voprosy` pitaniya. 2021. 90 (5). 104-114. doi: 10.33029/0042-8833-2021-90-5-104-114. in Russian.
35. Herbozo S., Flynn P.M., Stevens S.D., Betancourt H. Dietary Adherence, Glycemic Control, and Psychological Factors Associated with Binge Eating Among Indigenous and Non-Indigenous Chileans with Type 2 Diabetes. International Journal of Behavioral Medicine. 2015. 22 (6). 792-798. doi: 10.1007/s12529-015-9478-y.
36. Sakai R., Hashimoto Y., Ushigome E., Miki A., Okamura T., Matsugasumi M., Fukui M. Late-night-dinner is associated with poor glycemic control in people with type 2 diabetes: The KAMOGAWA-DM cohort study. Endocrine Journal. 2017. 65 (4). 395-402. doi: 10.1507/endocrj.ej17-0414
37. Joseph M., Shyamasunder A.H., Mammen P., Thomas N. Type 1 diabetes mellitus and eating disorders. International Journal of Diabetes in Developing Countries. 2016. 37 (4). 502-506. doi: 10.1007/s13410-016-0530-5.
38. Berger G., Waldhoer T., Barrientos I., Kunkel D., Rami-Merhar B.M., Schober E., Wagner G. Association of insulin-manipulation and psychiatric disorders: A systematic epidemiological evaluation of adolescents with type 1 diabetes in Austria. Pediatric Diabetes. 2018. doi: 10.1111/pedi.12784.
39. Cherubini V., Skrami E., Iannilli A., Cesaretti A., Paparusso A. M., Alessandrelli M. C., Gesuita R. Disordered eating behaviors in adolescents with type 1 diabetes: A cross-sectional population-based study in Italy. International Journal of Eating Disorders. 2018. doi: 10.1002/eat.22889.
Review
For citations:
Isakova D.N., Petrov I.M., Evgenyeva E.A., Kurmangulov A.A., Troshina I.A., Vasilkova T.N. Eating disorders: predictors of development in disorders of carbohydrate metabolism. Transbaikalian Medical Bulletin. 2023;(1):137-148. (In Russ.) https://doi.org/10.52485/19986173_2023_1_137
Views:
107
Email this article 